Forepont Capital Partners
Venture capitalNew York · Pre-Seed–Late Stage · 26 people tracked
Also known as FOREPONT CAPITAL LLC
Find your way into Forepont Capital Partners
996 people in our graph share verified history with the Forepont Capital Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Forepont Capital Partners invests in early-stage companies before their inflection point, targeting ventures with the potential to improve the lives of millions. Its focus centers on 'Brain AI' — artificial intelligence that advances neuroscience — and applications of that technology across healthcare, safety, education, defense, and device control. The firm also backs biological frameworks that improve AI performance and efficiency and unlock new capabilities. Forepont typically retains a board seat in most portfolio companies, sizing its positions to maintain influence, and supports its companies scientifically, technologically, and strategically through its expertise and network.
Source: firm website, verified Sep 15, 2026.
Team · 26 people
from the firm's website & curated & public directories
What they invest in
from 15 of 16 portfolio companiesMedical Devices ×10Biotech ×7Healthtech ×7Deep Tech ×6Digital Health ×5AI & Machine Learning ×3Enterprise Software ×2SaaS ×2
HQs:France×5United States×5
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×53 founders×1
Investments · 16 tracked
founders shown can be your intro pathBy year:2025 · 32024 · 12023 · 12021 · 12018 · 17 dated
Restera develops neurostimulation and sleep therapy medical devices, bringing over 75 years of combined expertise in these areas with 100+ FDA approvals.
Deep TechHardwareHealthtechMedical Devices
Rick O'Connor(CEO)
Co-investorsSupermoon CapitalAphelion CapitalDns CapitalGreatPoint Ventures
Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.
BiotechFemTechMedical DevicesAustin, US
BCV Systems develops a mechatronic guidewire system using shape memory alloy actuators to optimize navigation during minimally invasive endovascular procedures for stroke treatment and other vascular interventions.
Deep TechHealthtechMedical DevicesParis, FR
Dr Raphaël Blanc(President)Jérôme Szewczyk(Researcher at the Institute of Intelligent Systems and Robotics ISIR, Professor at Sorbonne University)Jean-Baptiste Cazeneuve(CTO, Mechatronic Engineer)in
BayBridgeDigital is a Salesforce consulting firm that helps retailers, healthcare, real estate, education, and hospitality companies with digital transformation through CRM implementation, data management, and cloud platform integration.
Data & InfrastructureEnterprise SoftwareSaaSNew York, US
Alain Attias(Founder)inGuy Jerusalmi(Executive Officer)
BeCareLink builds AI-enhanced mobile platforms for remote neurological assessments, allowing patients to monitor their neurological health from home while helping clinicians and researchers track disease progression.
AI & Machine LearningDigital HealthHealthtech
Lawrence Rubin(Co-founder)Charisse D. Litchman(Co-founder)
BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2.
BiotechHealthtechMedical Devices
Evelyne Begaud(Co-founder & President)Yves Germani(Co-founder & Chief Scientific Officer)in
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.
BiotechDeep TechMedical Devices
Florian Solzbacher(Co-Founder & CSO)inMarcus Gerhardt(Co-Founder & CEO)inThomas Thiele(CFO)in
BoardChristian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)
Co-investors2050 CapitalCatalio Capital Management, LPTether
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).
BiotechDeep TechDigital HealthMedical DevicesParis, FR
Harry Sokol(Scientific Co-founder)in
Co-investorsBpifranceAgoranovAuriga PartnersUI Investissement
GPN Vaccines is a clinical-stage company developing vaccines against bacterial pathogens, including a vaccine to prevent pneumococcal disease.
BiotechHealthtechNew York, US
Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in
Co-investorsKern Capital, LLCShearwater Capital
Okeiro is a medical platform using predictive algorithms to monitor transplant and chronic disease patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsRed River WestAlven
Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.
Deep TechDigital HealthMedical Devices
Co-investorsB Capital GroupB4 CapitalDraper AssociatesSteadview Capital
.jpeg){kind=logo}
Precision is an AI platform paired with operators who build, train, and run AI agents across a company's marketing, delivery, support, operations, and finance functions.
AI & Machine LearningEnterprise SoftwareSaaS
Matt Verlaque(Founder)in
Co-investorsRevUp Capital216 CapitalAlumni VenturesB CapitalB Capital GroupDraper Associates+3 more
HealthtechNew York, US
Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)
BoardEric M. Attias(Director)inHoward Morgan(Director)in
Co-investorsAlumni VenturesB Capital GroupBasecamp FundSCI VenturesSteadview Capital
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.
BiotechDeep TechMedical DevicesCampbell, US
Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)inThomas Oxley(Founder)in
BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)
Co-investorsARCH Venture PartnersID8 InvestmentsKaleida CapitalKhosla VenturesBezos ExpeditionsIn-Q-Tel+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Invicta Medical
Portfolio news
latest coverage across their companies
Precision · igrownews.com · Aug 22, 2026
Blackrock Neurotech · neurotechreports.com · Aug 20, 2026
Precision · dabafinance.com · Jun 25, 2026
Restera · nasdaqprivatemarket.com · Apr 3, 2026
Precision Neuroscience · trysignalbase.com · Mar 9, 2026
Synchron · medtechdive.com · Nov 7, 2025
Frequently asked questions
- How many investments has Forepont Capital Partners made?
- Forepont Capital Partners has 16 tracked investments, including 3 dated in the last 24 months.
- What stage does Forepont Capital Partners invest at?
- Forepont Capital Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Forepont Capital Partners focus on?
- Forepont Capital Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Defense Tech, EdTech, Healthtech, Medical Devices.
- Where is Forepont Capital Partners located?
- Forepont Capital Partners is headquartered in New York, US.
- Does Forepont Capital Partners lead rounds?
- Yes, Forepont Capital Partners leads investment rounds.
- Who does Forepont Capital Partners co-invest with?
- Forepont Capital Partners most often shares deals with ARCH Venture Partners, B Capital Group, Draper Associates, among 13 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Olive Tree Capital is a venture capital firm that invests in founders building at the technological frontier.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.